Shareholders Equity: The sum of preferred and common equity items.
NeoGenomics, Inc. (NEO) had Shareholders Equity of $854.04M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$181.33M |
|
$-45.09M |
|
$104.07M |
|
$77.26M |
|
$228.96M |
|
$-47.63M |
|
$1.81M |
|
$-45.82M |
|
$-45.82M |
|
$-45.09M |
|
$-45.09M |
|
$-45.09M |
|
$-45.09M |
|
$-47.63M |
|
$-29.87M |
|
127.95M |
|
127.95M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$392.55M |
|
$85.46M |
|
$1.00B |
|
$1.39B |
|
$100.12M |
|
$341.10M |
|
$439.79M |
|
$539.91M |
|
$854.04M |
|
$28.10M |
|
|
Shareholders Equity |
$854.04M |
128.68M |
|
| Cash Flow Statement Financials | |
$-5.00M |
|
$-5.75M |
|
$-201.48M |
|
$367.01M |
|
$154.72M |
|
$-212.29M |
|
$22.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.92 |
|
-- |
|
-- |
|
0.29 |
|
0.40 |
|
42.61% |
|
-26.27% |
|
-26.27% |
|
-- |
|
-25.27% |
|
-24.87% |
|
$-15.82M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
3.05 |
|
1.18 |
|
76.00 |
|
-5.28% |
|
-160.46% |
|
-3.23% |
|
-3.77% |
|
$6.64 |
|
$-0.12 |
|
$-0.04 |
|